Compound Radar

Avantor, Inc. (AVTR) Stock Analysis

Price $15.25
Market cap $10.31B
Next earnings Oct 28, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

51
51/100 Speculative
  • Financial Health 65
  • Profitability 30
  • Business Quality 60
  • Balance Sheet 40
  • Cash Flow 45

Why this rating?

Health 51/100 — Speculative

Strongest Financial Health 65/100
Softest Profitability 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Avantor, Inc. (AVTR) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Avantor, Inc. 51/100 (Speculative) due to solid business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • Forward P/E 17.29
  • EV/Revenue 2.06

Profitability

  • Revenue Growth 0.5%
  • Gross Margin 31.8%
  • Operating Margin 7.2%
  • Net Margin -8.8%
  • ROE -9.7%

Financial strength

  • Cash $306.80M
  • Debt $3.70B
  • Net Cash $-3.39B
  • Free Cash Flow $495.00M
  • Current Ratio 1.78

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Avantor, Inc. (AVTR).

View Methodology & FAQ →